|
|
 |
|
|
|
| Éditorial |
|
Recommandations pour l’hypertension portale
Dominique-Charles Valla, Didier Lebrec
|
 Article gratuit
|
|
| Mini-revue |
|
Relaxations transitoires du sphincter inférieur de l’œsophage et traitement du reflux gastro-œsophagien
Abdourhamane D Diallo, Stanislas Bruley des Varannes
|
Résumé
Article gratuit
|
Le génotype 5 du virus de l’hépatite C
Florence Legrand-Abravanel, Karine Sandres-Sauné, Christophe Pasquier, Karl Barange, Laurent Alric, Jacques Izopet
|
Résumé
Article gratuit
|
Pronostic du malade cirrhotique en réanimation
René Robert, Hodanou Nanadoumgar
|
Résumé
Article gratuit
|
Traitement endoscopique de l’hémorragie diverticulaire
Gilles Lesur
|
Résumé
Article gratuit
|
|
| Cas clinique commenté |
|
Abdomen aigu chez un malade hémodialysé : songez au cristal
*!
Abdelkader Mordi, Christian Sevestre, Khaled Al Chaar, Véronique Debuire, Francine Lecointre, Sylvain Bauland
|
Article gratuit
|
|
| Bases fondamentales |
|
Protéomique et spectrométrie de masse : applications en clinique
Frédéric Lopez
|
Résumé
Article gratuit
|
|
| Informations‐BrÈves |
|
A59. The effect of tegaserod on esophageal function : a randomized control trial in healthy volunteers.
Fox M, Fried M, Menne D, Stutz B, Scwizer W.
|
|
A499. The plicator
TM procedure for the treatment of GERD : 12-month multicenter results.
Haber G, Sakai P, Moura E, Maluf-Fiho F, Enns R, Pleskow D,
et al.
|
|
A545. Randomised double blind cross over study evaluating the effect of intrapyloric injection of botulinum toxin on gastric emptying and symptoms in patients with gastroparesis.
Arts J, Canepeel P, Degreef T, Gebruers K, Verbeke K, Janssens J, Tack J.
|
|
A407. Effect of ghrelin on gastric emptying in patients with neurogenic gastroparesis.
Binn M, Albert C, Gougeon A, Rabasa-Lhoret R, Havrankova J, Lemoyne M,
et al.
|
|
A901. Gastrokinetic effect of ghrelin analogue Rc-1139 on post-operative and on morphine induced ileus in rat.
Poitras P, Rocheleau B, Polvino W.
|
|
A248. Application of L-erythro mÉthoxamine gel increases anal resting pressure in patients with passive faecal incontinence.
Nisar P, Gruss H, Bush D, Thompson J, Barras N, Scholefield J.
|
|
A158. Post-infectious irritable bowel syndrome (IBS) after theWalkerton outbreak of waterborne gastroenteritis.
Marshall JK, Thabane M, Garg AX, Macnanb J, Clark W, Howard J,
et al.
|
|
A 403. Colonic mucosal mast cell mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons.
Barbara G, Cremon C, Riccardo V, Elisabeta C, Balestra B, Di Nardo G,
et al.
|
|
A159. Cilansetron is efficacious in treating diarrhoeal symptoms in irritable bowel syndrome with diarrhea predominance (IBS-D) over 3 months.
Thierry Piche, Miner PB, Pruitt RE, Carter S, Caras S, Krause G, Steinborn C.
|
|
Combined oral and enema treatment with pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis : a randomised, double
blind, placebo controlled study.
Gut 2005 ; 54 : 960-5.
Thierry Piche, Marteau P, Probert CS, Lindgren S, Gassul M, Tan TG, Dignass A,
et al.
|
|
Growth, phenotype, and function of human intestinal mast cells are highly regulated by transforming growth factor 1. Gut 2005 ; 54 : 928-34
Thierry Piche, Gebhardt T, Lorentz A, Detmer F, Trautwein C, Bektas H, Manns MP, Bischoff SC.
|
|
La radiofrÉquence selon le procÉdÉ Stretta rÉduit la distensibilitÉ de la jonction oesogastrique chez des patients ayant un RGO
|
|
|
|
